Attenuated Listeria monocytogenes (LM), as an immune modulator and vaccine adjuvant, induces a strong cellular immunity characterized by Th1-type CD4 T cell and CD8 T cell activation, has been successfully developed and used as a vaccine carrier and is a attractive TB vaccine vehicle for delivering M.tb antigens. Here, CD8A is linked to tuberculosis.